| Clip | Code No. | Product | Data | ||||
|---|---|---|---|---|---|---|---|
| Data
Sheet |
Category | Conjugate | MHC Allele | Size | Price | Availability | |
| Sequence | Location (aa) | Storage
temp. |
|||||
|
|
|||||||
|
TC-8030-2 |
HLA-A*03:01 KRAS7-16 G12C Tetramer-VVVGACGVGK-APC |
|
||||
|
cancer | APC | A*03:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVVGACGVGK | 7-16 | 4°C | |||||
|
TC-8022-1 |
HLA-A*11:01 KRAS7-16 G12C Tetramer-VVVGACGVGK-PE |
|
||||
|
cancer | PE | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVVGACGVGK | 7-16 | 4°C | |||||
|
TS-M274-2 |
HLA-B*07:02 Filamin A Neoepitope Tetramer-CVRVSGQGL-APC |
|
||||
|
cancer | APC | B*07:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| CVRVSGQGL | 4°C | ||||||
|
TS-M251-1 |
HLA-A*03:01 SIRT2 Neoepitope Tetramer-KIFSEVTLK-PE |
|
||||
|
cancer | PE | A*03:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KIFSEVTLK | 4°C | ||||||
|
TS-M243-1 |
HLA-A*02:01 UGCGL2 Neoepitope Tetramer-GLLDEDFYA-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| GLLDEDFYA | 4°C | ||||||
|
TS-M202-1 |
HLA-A*01:01 NRAS Neoepitope Tetramer-ILDTAGREEY-PE |
|
||||
|
cancer | PE | A*01:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| ILDTAGREEY | 4°C | ||||||
|
TC-8029-1 |
HLA-A*03:01 KRAS8-16 G12C Tetramer-VVGACGVGK-PE |
|
||||
|
cancer | PE | A*03:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVGACGVGK | 8-16 | 4°C | |||||
|
TC-8021-2 |
HLA-A*11:01 KRAS7-16 G12A Tetramer-VVVGAAGVGK-APC |
|
||||
|
cancer | APC | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVVGAAGVGK | 7-16 | 4°C | |||||
|
TC-8004-2 |
HLA-A*11:01 KRAS8-16 G12V Tetramer-VVGAVGVGK-APC |
|
||||
|
cancer | APC | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVGAVGVGK | 8-16 | 4°C | |||||
|
TS-M613-2 |
H-2Kb GLMP Tetramer-SALVFTRL-APC |
|
||||
|
cancer | APC | H-2Kb | 50 tests | ¥209,000 |
0 (Contact us) |
|
| SALVFTRL | 119-126 | 4°C | |||||
|
TS-M202-2 |
HLA-A*01:01 NRAS Neoepitope Tetramer-ILDTAGREEY-APC |
|
||||
|
cancer | APC | A*01:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| ILDTAGREEY | 4°C | ||||||
|
TS-M252-1 |
HLA-A*03:01 PRPF6 Neoepitope Tetramer-KILDAVVAQK-PE |
|
||||
|
cancer | PE | A*03:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KILDAVVAQK | 4°C | ||||||
|
TC-8030-1 |
HLA-A*03:01 KRAS7-16 G12C Tetramer-VVVGACGVGK-PE |
|
||||
|
cancer | PE | A*03:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVVGACGVGK | 7-16 | 4°C | |||||
|
TC-8026-1 |
HLA-A*24:02 NY-ESO-1158-166 Tetramer-LLMWITQCF-PE |
|
||||
|
cancer | PE | A*24:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| LLMWITQCF | 158-166 | 4°C | |||||
|
TC-8015-1 |
HLA-A*11:01 KRAS7-16 G13D Tetramer-VVVGAGDVGK-PE |
|
||||
|
cancer | PE | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVVGAGDVGK | 7-16 | 4°C | |||||
|
TC-8005-2 |
HLA-A*11:01 KRAS8-16 WT Tetramer-VVGAGGVGK-APC |
|
||||
|
cancer | APC | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVGAGGVGK | 8-16 | 4°C | |||||
|
TC-8001-2 |
HLA-A*11:01 KRAS7-16 G12D Tetramer-VVVGADGVGK-APC |
|
||||
|
cancer | APC | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVVGADGVGK | 7-16 | 4°C | |||||
|
TS-M272-1 |
HLA-B*07:02 MLL3 Neoepitope Tetramer-KPSDTPRPVM-PE |
|
||||
|
cancer | PE | B*07:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KPSDTPRPVM | 4°C | ||||||
|
TS-M269-1 |
HLA-B*07:02 UBR4 Neoepitope Tetramer-RPHVPESAF-PE |
|
||||
|
cancer | PE | B*07:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| RPHVPESAF | 4°C | ||||||
|
TS-M263-1 |
HLA-A*11:01 Perilipin-2 Tetramer-TSALPIIQK-PE |
|
||||
|
cancer | PE | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| TSALPIIQK | 63-71 | 4°C | |||||
|
TS-M255-1 |
HLA-A*03:01 ATR Neoepitope Tetramer-KLYEEPLLK-PE |
|
||||
|
cancer | PE | A*03:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KLYEEPLLK | 4°C | ||||||
|
TS-M201-1 |
HLA-A*01:01 TRIP12 Neoepitope Tetramer-PSDTRQMLFY-PE |
|
||||
|
cancer | PE | A*01:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| PSDTRQMLFY | 4°C | ||||||
|
TC-8033-2 |
HLA-A*03:01 KRAS8-16 WT Tetramer-VVGAGGVGK-APC |
|
||||
|
cancer | APC | A*03:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVGAGGVGK | 8-16 | 4°C | |||||
|
TC-8017-1 |
HLA-A*02:01 AFP158-166 Tetramer-FMNKFIYEI-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| FMNKFIYEI | 158-166 | 4°C | |||||
|
TS-M273-2 |
HLA-B*07:02 TTBK2 Neoepitope Tetramer-RPHHDQRSL-APC |
|
||||
|
cancer | APC | B*07:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| RPHHDQRSL | 4°C | ||||||
|
TS-M262-2 |
HLA-A*11:01 KIF26B Neoepitope Tetramer-SSYTGFANK-APC |
|
||||
|
cancer | APC | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| SSYTGFANK | 4°C | ||||||
|
TS-M613-1 |
H-2Kb GLMP Tetramer-SALVFTRL-PE |
|
||||
|
cancer | PE | H-2Kb | 50 tests | ¥209,000 |
0 (Contact us) |
|
| SALVFTRL | 119-126 | 4°C | |||||
|
TS-M276-1 |
HLA-B*07:02 DOPEY2 Neoepitope Tetramer-KPFCVLISL-PE |
|
||||
|
cancer | PE | B*07:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KPFCVLISL | 4°C | ||||||
|
TS-M267-1 |
HLA-A*24:02 LOK Tetramer-SYQKVIELF-PE |
|
||||
|
cancer | PE | A*24:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| SYQKVIELF | 289-297 | 4°C | |||||
|
TS-M259-1 |
HLA-A*11:01 HERC1 Neoepitope Tetramer-ASNASSAAK-PE |
|
||||
|
cancer | PE | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| ASNASSAAK | 4°C | ||||||
|
TS-M242-1 |
HLA-A*02:01 MCT2 Neoepitope Tetramer-AMAGSLVFL-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| AMAGSLVFL | 4°C | ||||||
|
TC-8034-2 |
HLA-A*03:01 KRAS7-16 WT Tetramer-VVVGAGGVGK-APC |
|
||||
|
cancer | APC | A*03:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVVGAGGVGK | 7-16 | 4°C | |||||
|
TC-8032-2 |
HLA-A*03:01 KRAS7-16 G12V Tetramer-VVVGAVGVGK-APC |
|
||||
|
cancer | APC | A*03:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVVGAVGVGK | 7-16 | 4°C | |||||
|
TC-8021-1 |
HLA-A*11:01 KRAS7-16 G12A Tetramer-VVVGAAGVGK-PE |
|
||||
|
cancer | PE | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVVGAAGVGK | 7-16 | 4°C | |||||
|
TC-8015-2 |
HLA-A*11:01 KRAS7-16 G13D Tetramer-VVVGAGDVGK-APC |
|
||||
|
cancer | APC | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVVGAGDVGK | 7-16 | 4°C | |||||
|
TC-8014-2 |
HLA-A*11:01 KRAS7-16 WT Tetramer-VVVGAGGVGK-APC |
|
||||
|
cancer | APC | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVVGAGGVGK | 7-16 | 4°C | |||||
|
TC-8012-2 |
HLA-A*11:01 KRAS7-16 G12R Tetramer-VVVGARGVGK-APC |
|
||||
|
cancer | APC | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVVGARGVGK | 7-16 | 4°C | |||||
|
TC-8009-1 |
HLA-A*02:01 MAGE-A4286-294 Tetramer-KVLEHVVRV-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KVLEHVVRV | 286-294 | 4°C | |||||
|
TC-8004-1 |
HLA-A*11:01 KRAS8-16 G12V Tetramer-VVGAVGVGK-PE |
|
||||
|
cancer | PE | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVGAVGVGK | 8-16 | 4°C | |||||
|
TC-8003-2 |
HLA-A*11:01 KRAS7-16 G12V Tetramer-VVVGAVGVGK-APC |
|
||||
|
cancer | APC | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVVGAVGVGK | 7-16 | 4°C | |||||
|
TC-8003-1 |
HLA-A*11:01 KRAS7-16 G12V Tetramer-VVVGAVGVGK-PE |
|
||||
|
cancer | PE | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVVGAVGVGK | 7-16 | 4°C | |||||
|
TS-M276-2 |
HLA-B*07:02 DOPEY2 Neoepitope Tetramer-KPFCVLISL-APC |
|
||||
|
cancer | APC | B*07:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KPFCVLISL | 4°C | ||||||
|
TS-M272-2 |
HLA-B*07:02 MLL3 Neoepitope Tetramer-KPSDTPRPVM-APC |
|
||||
|
cancer | APC | B*07:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KPSDTPRPVM | 4°C | ||||||
|
TS-M263-2 |
HLA-A*11:01 Perilipin-2 Tetramer-TSALPIIQK-APC |
|
||||
|
cancer | APC | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| TSALPIIQK | 63-71 | 4°C | |||||
|
TS-M254-2 |
HLA-A*03:01 MYO1B Neoepitope Tetramer-KINKNPKYK-APC |
|
||||
|
cancer | APC | A*03:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KINKNPKYK | 4°C | ||||||
|
TS-M252-2 |
HLA-A*03:01 PRPF6 Neoepitope Tetramer-KILDAVVAQK-APC |
|
||||
|
cancer | APC | A*03:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KILDAVVAQK | 4°C | ||||||
|
TS-M277-1 |
HLA-B*08:01 FAM50B Neoepitope Tetramer-DMKARQKALV-PE |
|
||||
|
cancer | PE | B*08:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| DMKARQKALV | 4°C | ||||||
|
TS-M275-1 |
HLA-B*07:02 MYADM Neoepitope Tetramer-SPMIVGSPW-PE |
|
||||
|
cancer | PE | B*07:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| SPMIVGSPW | 4°C | ||||||
|
TS-M246-1 |
HLA-A*02:01 GOLGA3 Neoepitope Tetramer-SLDLTTSPV-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| SLDLTTSPV | 4°C | ||||||
|
TS-M230-1 |
HLA-A*02:01 USP28 Neoepitope Tetramer-LIIPFIHLI-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| LIIPFIHLI | 4°C | ||||||
|
TC-8029-2 |
HLA-A*03:01 KRAS8-16 G12C Tetramer-VVGACGVGK-APC |
|
||||
|
cancer | APC | A*03:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVGACGVGK | 8-16 | 4°C | |||||
|
TC-8023-1 |
HLA-A*11:01 KRAS7-16 G12S Tetramer- VVVGASGVGK-PE |
|
||||
|
cancer | PE | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVVGASGVGK | 7-16 | 4°C | |||||
|
TC-8022-2 |
HLA-A*11:01 KRAS7-16 G12C Tetramer-VVVGACGVGK-APC |
|
||||
|
cancer | APC | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVVGACGVGK | 7-16 | 4°C | |||||
|
TC-8014-1 |
HLA-A*11:01 KRAS7-16 WT Tetramer-VVVGAGGVGK-PE |
|
||||
|
cancer | PE | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVVGAGGVGK | 7-16 | 4°C | |||||
|
TC-8013-1 |
HLA-A*02:01 KRAS5-14 G12C Tetramer-KLVVVGACGV-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KLVVVGACGV | 5-14 | 4°C | |||||
|
TC-8005-1 |
HLA-A*11:01 KRAS8-16 WT Tetramer-VVGAGGVGK-PE |
|
||||
|
cancer | PE | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVGAGGVGK | 8-16 | 4°C | |||||
|
TS-M270-2 |
HLA-B*07:02 KIF16B Neoepitope Tetramer-APARLERRHSA-APC |
|
||||
|
cancer | APC | B*07:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| APARLERRHSA | 4°C | ||||||
|
TS-M230-2 |
HLA-A*02:01 USP28 Neoepitope Tetramer-LIIPFIHLI-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| LIIPFIHLI | 4°C | ||||||
|
TS-M201-2 |
HLA-A*01:01 TRIP12 Neoepitope Tetramer-PSDTRQMLFY-APC |
|
||||
|
cancer | APC | A*01:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| PSDTRQMLFY | 4°C | ||||||
|
TS-M273-1 |
HLA-B*07:02 TTBK2 Neoepitope Tetramer-RPHHDQRSL-PE |
|
||||
|
cancer | PE | B*07:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| RPHHDQRSL | 4°C | ||||||
|
TS-M261-1 |
HLA-A*11:01 MATN2 Neoepitope Tetramer-KTLTSVFQK-PE |
|
||||
|
cancer | PE | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KTLTSVFQK | 4°C | ||||||
|
TS-M258-1 |
HLA-A*11:01 KRAS Neoepitope Tetramer-VVGAAGVGK-PE |
|
||||
|
cancer | PE | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVGAAGVGK | 4°C | ||||||
|
TS-M254-1 |
HLA-A*03:01 MYO1B Neoepitope Tetramer-KINKNPKYK-PE |
|
||||
|
cancer | PE | A*03:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KINKNPKYK | 4°C | ||||||
|
TS-M244-1 |
HLA-A*02:01 FNDC3B Neoepitope Tetramer-VVMSWAPPV-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVMSWAPPV | 4°C | ||||||
|
TS-M215-1 |
HLA-A*02:01 WDR46 Neoepitope Tetramer-FLIYLDVSV-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| FLIYLDVSV | 4°C | ||||||
|
TC-8024-2 |
HLA-A*02:01 KRAS5-14 WT Tetramer-KLVVVGAGGV-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KLVVVGAGGV | 5-14 | 4°C | |||||
|
TC-8019-2 |
HLA-A*02:01 MAGE-A2112-120 Tetramer-KMVELVHFL-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KMVELVHFL | 112-120 | 4°C | |||||
|
TC-8012-1 |
HLA-A*11:01 KRAS7-16 G12R Tetramer-VVVGARGVGK-PE |
|
||||
|
cancer | PE | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVVGARGVGK | 7-16 | 4°C | |||||
|
TC-8011-1 |
HLA-A*02:01 KRAS5-14 G12V Tetramer-KLVVVGAVGV-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KLVVVGAVGV | 5-14 | 4°C | |||||
|
TC-8009-2 |
HLA-A*02:01 MAGE-A4286-294 Tetramer-KVLEHVVRV-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KVLEHVVRV | 286-294 | 4°C | |||||
|
TS-M610-2 |
H-2Kb SGK1 Tetramer-STLTYSRM-APC |
|
||||
|
cancer | APC | H-2Kb | 50 tests | ¥209,000 |
0 (Contact us) |
|
| STLTYSRM | 10-17 | 4°C | |||||
|
TS-M269-2 |
HLA-B*07:02 UBR4 Neoepitope Tetramer-RPHVPESAF-APC |
|
||||
|
cancer | APC | B*07:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| RPHVPESAF | 4°C | ||||||
|
TS-M261-2 |
HLA-A*11:01 MATN2 Neoepitope Tetramer-KTLTSVFQK-APC |
|
||||
|
cancer | APC | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KTLTSVFQK | 4°C | ||||||
|
TS-M259-2 |
HLA-A*11:01 HERC1 Neoepitope Tetramer-ASNASSAAK-APC |
|
||||
|
cancer | APC | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| ASNASSAAK | 4°C | ||||||
|
TS-M253-2 |
HLA-A*03:01 GPNMB Neoepitope Tetramer-TLDWLLQTPK-APC |
|
||||
|
cancer | APC | A*03:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| TLDWLLQTPK | 4°C | ||||||
|
TS-M260-1 |
HLA-A*11:01 CDK13 Neoepitope Tetramer-CILGKLFTK-PE |
|
||||
|
cancer | PE | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| CILGKLFTK | 4°C | ||||||
|
TS-M253-1 |
HLA-A*03:01 GPNMB Neoepitope Tetramer-TLDWLLQTPK-PE |
|
||||
|
cancer | PE | A*03:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| TLDWLLQTPK | 4°C | ||||||
|
TS-M239-1 |
HLA-A*02:01 SPOP Neoepitope Tetramer-FLLDEAIGL-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| FLLDEAIGL | 4°C | ||||||
|
TS-M235-1 |
HLA-A*02:01 Filamin-A Neoepitope Tetramer-HIAKSLFEV-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| HIAKSLFEV | 4°C | ||||||
|
TC-8020-1 |
HLA-A*02:01 PSMA663-671 Tetramer-MMNDQLMFL-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| MMNDQLMFL | 663-671 | 4°C | |||||
|
TC-8002-1 |
HLA-A*11:01 KRAS8-16 G12D Tetramer-VVGADGVGK-PE |
|
||||
|
cancer | PE | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVGADGVGK | 8-16 | 4°C | |||||
|
TS-M277-2 |
HLA-B*08:01 FAM50B Neoepitope Tetramer-DMKARQKALV-APC |
|
||||
|
cancer | APC | B*08:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| DMKARQKALV | 4°C | ||||||
|
TS-M258-2 |
HLA-A*11:01 KRAS Neoepitope Tetramer-VVGAAGVGK-APC |
|
||||
|
cancer | APC | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVGAAGVGK | 4°C | ||||||
|
TS-M240-2 |
HLA-A*02:01 CK1α Neoepitope Tetramer-GLFGDIYLAI-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| GLFGDIYLAI | 4°C | ||||||
|
TS-M211-2 |
HLA-A*02:01 HER2 Neoepitope Tetramer-ALIHHNTYL-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| ALIHHNTYL | 4°C | ||||||
|
TS-M262-1 |
HLA-A*11:01 KIF26B Neoepitope Tetramer-SSYTGFANK-PE |
|
||||
|
cancer | PE | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| SSYTGFANK | 4°C | ||||||
|
TS-M247-1 |
HLA-A*02:01 AGMO Neoepitope Tetramer-ALLQVTLLL-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| ALLQVTLLL | 4°C | ||||||
|
TS-M238-1 |
HLA-A*02:01 SNAT1 Neoepitope Tetramer-ILAALFLGL-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| ILAALFLGL | 4°C | ||||||
|
TS-M227-1 |
HLA-A*02:01 KMT2D Neoepitope Tetramer-ALSPVIPHI-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| ALSPVIPHI | 4°C | ||||||
|
TS-M224-1 |
HLA-A*02:01 CDC37L1 Neoepitope Tetramer-FLSDHLYLV-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| FLSDHLYLV | 4°C | ||||||
|
TS-M221-1 |
HLA-A*02:01 GANAB Neoepitope Tetramer-ALYGFVPVL-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| ALYGFVPVL | 4°C | ||||||
|
TS-M216-1 |
HLA-A*02:01 HAUS3 Neoepitope Tetramer-ILNAMIAKI-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| ILNAMIAKI | 4°C | ||||||
|
TC-8020-2 |
HLA-A*02:01 PSMA663-671 Tetramer-MMNDQLMFL-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| MMNDQLMFL | 663-671 | 4°C | |||||
|
TC-8019-1 |
HLA-A*02:01 MAGE-A2112-120 Tetramer-KMVELVHFL-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KMVELVHFL | 112-120 | 4°C | |||||
|
TC-8017-2 |
HLA-A*02:01 AFP158-166 Tetramer-FMNKFIYEI-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| FMNKFIYEI | 158-166 | 4°C | |||||
|
TC-8013-2 |
HLA-A*02:01 KRAS5-14 G12C Tetramer-KLVVVGACGV-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KLVVVGACGV | 5-14 | 4°C | |||||
|
TC-8011-2 |
HLA-A*02:01 KRAS5-14 G12V Tetramer-KLVVVGAVGV-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KLVVVGAVGV | 5-14 | 4°C | |||||
|
TS-M275-2 |
HLA-B*07:02 MYADM Neoepitope Tetramer-SPMIVGSPW-APC |
|
||||
|
cancer | APC | B*07:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| SPMIVGSPW | 4°C | ||||||
|
TS-M260-2 |
HLA-A*11:01 CDK13 Neoepitope Tetramer-CILGKLFTK-APC |
|
||||
|
cancer | APC | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| CILGKLFTK | 4°C | ||||||
|
TS-M214-2 |
HLA-A*02:01 COL18A1 Neoepitope Tetramer-VLLGVKLFGV-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VLLGVKLFGV | 4°C | ||||||